TipRanks
Go Ultimate55% OFF

Heron Therapeutics (HRTX) Balance Sheet

Heron Therapeutics Balance Sheet

Heron Therapeutics's total assets for Q2 2026 were $252.26M, an increase of 2.46% from the previous quarter. HRTX total liabilities were $245.35M for the fiscal quarter, a 3.49% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 255.88M$ 233.15M$ 222.51M$ 250.95M$ 305.71M
$ 241.54M$ 266.80M$ 256.48M$ 237.38M$ 228.14M
$ 14.33M$ -33.65M$ -33.97M$ 13.57M$ 77.57M

Currency in USD

Heron Therapeutics Debt to Assets

0200M400M600M0 %50 %100 %150 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets